Selected research
Industry Growth & Trends
Global Second Generation Sulfonylureas Industry Growth and Trends Forecast to 2032
Market perspective
The global Second Generation Sulfonylureas market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Second Generation Sulfonylureas include United Laboratories, Yiling Pharmaceutical, Takeda, Sanofi, Novo Nordisk, Merck, Eli Lilly, Jiangsu Hengrui Pharmaceuticals and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Second Generation Sulfonylureas market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Second Generation Sulfonylureas market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Second Generation Sulfonylureas market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Second Generation Sulfonylureas.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Second Generation Sulfonylureas market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Second Generation Sulfonylureas Market by Company
United Laboratories
Yiling Pharmaceutical
Takeda
Sanofi
Novo Nordisk
Merck
Eli Lilly
Jiangsu Hengrui Pharmaceuticals
Pfizer
Beijing Double-Crane Pharmaceutical
Huadong Medicine
Beijing Beilu Pharmaceutical
AstraZeneca
Boehringer Ingelheim
Second Generation Sulfonylureas Segment by Type
Glyburide
Glipizide
Gliclazide
Others
Second Generation Sulfonylureas Segment by Application
Clinic
Hospital
Pharmacy
Others
Second Generation Sulfonylureas Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Second Generation Sulfonylureas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Second Generation Sulfonylureas and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Second Generation Sulfonylureas.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Second Generation Sulfonylureas manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Second Generation Sulfonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glyburide
- Glipizide
- Gliclazide
- Others
Applications
- Clinic
- Hospital
- Pharmacy
- Others
Companies covered
- United Laboratories
- Yiling Pharmaceutical
- Takeda
- Sanofi
- Novo Nordisk
- Merck
- Eli Lilly
- Jiangsu Hengrui Pharmaceuticals
- Pfizer
- Beijing Double-Crane Pharmaceutical
- Huadong Medicine
- Beijing Beilu Pharmaceutical
- AstraZeneca
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Second Generation Sulfonylureas Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Second Generation Sulfonylureas Sales Estimates and Forecasts (2021-2032)
- 1.3 Second Generation Sulfonylureas Market by Type
- 1.3.1 Glyburide
- 1.3.2 Glipizide
- 1.3.3 Gliclazide
- 1.3.4 Others
- 1.4 Global Second Generation Sulfonylureas Market Size by Type
- 1.4.1 Global Second Generation Sulfonylureas Market Size Overview by Type (2021-2032)
- 1.4.2 Global Second Generation Sulfonylureas Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Second Generation Sulfonylureas Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Second Generation Sulfonylureas Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Second Generation Sulfonylureas Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Second Generation Sulfonylureas Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Second Generation Sulfonylureas Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Second Generation Sulfonylureas Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Second Generation Sulfonylureas Industry Trends
- 2.2 Second Generation Sulfonylureas Industry Drivers
- 2.3 Second Generation Sulfonylureas Industry Opportunities and Challenges
- 2.4 Second Generation Sulfonylureas Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Second Generation Sulfonylureas Revenue (2021-2026)
- 3.2 Global Top Players by Second Generation Sulfonylureas Sales (2021-2026)
- 3.3 Global Top Players by Second Generation Sulfonylureas Price (2021-2026)
- 3.4 Global Second Generation Sulfonylureas Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Second Generation Sulfonylureas Major Company Production Sites & Headquarters
- 3.6 Global Second Generation Sulfonylureas Company, Product Type & Application
- 3.7 Global Second Generation Sulfonylureas Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Second Generation Sulfonylureas Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Second Generation Sulfonylureas Players Market Share by Revenue in 2025
- 3.8.3 2025 Second Generation Sulfonylureas Tier 1, Tier 2, and Tier 3
4 Second Generation Sulfonylureas Regional Status and Outlook
- 4.1 Global Second Generation Sulfonylureas Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Second Generation Sulfonylureas Historic Market Size by Region
- 4.2.1 Global Second Generation Sulfonylureas Sales in Volume by Region (2021-2026)
- 4.2.2 Global Second Generation Sulfonylureas Sales in Value by Region (2021-2026)
- 4.2.3 Global Second Generation Sulfonylureas Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Second Generation Sulfonylureas Forecasted Market Size by Region
- 4.3.1 Global Second Generation Sulfonylureas Sales in Volume by Region (2027-2032)
- 4.3.2 Global Second Generation Sulfonylureas Sales in Value by Region (2027-2032)
- 4.3.3 Global Second Generation Sulfonylureas Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Second Generation Sulfonylureas by Application
- 5.1 Second Generation Sulfonylureas Market by Application
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Pharmacy
- 5.1.4 Others
- 5.2 Global Second Generation Sulfonylureas Market Size by Application
- 5.2.1 Global Second Generation Sulfonylureas Market Size Overview by Application (2021-2032)
- 5.2.2 Global Second Generation Sulfonylureas Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Second Generation Sulfonylureas Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Second Generation Sulfonylureas Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Second Generation Sulfonylureas Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Second Generation Sulfonylureas Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Second Generation Sulfonylureas Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Second Generation Sulfonylureas Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 United Laboratories
- 6.1.1 United Laboratories Company Information
- 6.1.2 United Laboratories Business Overview
- 6.1.3 United Laboratories Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 United Laboratories Second Generation Sulfonylureas Product Portfolio
- 6.1.5 United Laboratories Recent Developments
- 6.2 Yiling Pharmaceutical
- 6.2.1 Yiling Pharmaceutical Company Information
- 6.2.2 Yiling Pharmaceutical Business Overview
- 6.2.3 Yiling Pharmaceutical Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Yiling Pharmaceutical Second Generation Sulfonylureas Product Portfolio
- 6.2.5 Yiling Pharmaceutical Recent Developments
- 6.3 Takeda
- 6.3.1 Takeda Company Information
- 6.3.2 Takeda Business Overview
- 6.3.3 Takeda Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Takeda Second Generation Sulfonylureas Product Portfolio
- 6.3.5 Takeda Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sanofi Second Generation Sulfonylureas Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 Novo Nordisk
- 6.5.1 Novo Nordisk Company Information
- 6.5.2 Novo Nordisk Business Overview
- 6.5.3 Novo Nordisk Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Novo Nordisk Second Generation Sulfonylureas Product Portfolio
- 6.5.5 Novo Nordisk Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Merck Second Generation Sulfonylureas Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Eli Lilly
- 6.7.1 Eli Lilly Company Information
- 6.7.2 Eli Lilly Business Overview
- 6.7.3 Eli Lilly Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Eli Lilly Second Generation Sulfonylureas Product Portfolio
- 6.7.5 Eli Lilly Recent Developments
- 6.8 Jiangsu Hengrui Pharmaceuticals
- 6.8.1 Jiangsu Hengrui Pharmaceuticals Company Information
- 6.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
- 6.8.3 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Product Portfolio
- 6.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
- 6.9 Pfizer
- 6.9.1 Pfizer Company Information
- 6.9.2 Pfizer Business Overview
- 6.9.3 Pfizer Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Pfizer Second Generation Sulfonylureas Product Portfolio
- 6.9.5 Pfizer Recent Developments
- 6.10 Beijing Double-Crane Pharmaceutical
- 6.10.1 Beijing Double-Crane Pharmaceutical Company Information
- 6.10.2 Beijing Double-Crane Pharmaceutical Business Overview
- 6.10.3 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Product Portfolio
- 6.10.5 Beijing Double-Crane Pharmaceutical Recent Developments
- 6.11 Huadong Medicine
- 6.11.1 Huadong Medicine Company Information
- 6.11.2 Huadong Medicine Business Overview
- 6.11.3 Huadong Medicine Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Huadong Medicine Second Generation Sulfonylureas Product Portfolio
- 6.11.5 Huadong Medicine Recent Developments
- 6.12 Beijing Beilu Pharmaceutical
- 6.12.1 Beijing Beilu Pharmaceutical Company Information
- 6.12.2 Beijing Beilu Pharmaceutical Business Overview
- 6.12.3 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Product Portfolio
- 6.12.5 Beijing Beilu Pharmaceutical Recent Developments
- 6.13 AstraZeneca
- 6.13.1 AstraZeneca Company Information
- 6.13.2 AstraZeneca Business Overview
- 6.13.3 AstraZeneca Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 AstraZeneca Second Generation Sulfonylureas Product Portfolio
- 6.13.5 AstraZeneca Recent Developments
- 6.14 Boehringer Ingelheim
- 6.14.1 Boehringer Ingelheim Company Information
- 6.14.2 Boehringer Ingelheim Business Overview
- 6.14.3 Boehringer Ingelheim Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Boehringer Ingelheim Second Generation Sulfonylureas Product Portfolio
- 6.14.5 Boehringer Ingelheim Recent Developments
7 North America by Country
- 7.1 North America Second Generation Sulfonylureas Sales by Country
- 7.1.1 North America Second Generation Sulfonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Second Generation Sulfonylureas Sales by Country (2021-2026)
- 7.1.3 North America Second Generation Sulfonylureas Sales Forecast by Country (2027-2032)
- 7.2 North America Second Generation Sulfonylureas Market Size by Country
- 7.2.1 North America Second Generation Sulfonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Second Generation Sulfonylureas Market Size by Country (2021-2026)
- 7.2.3 North America Second Generation Sulfonylureas Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Second Generation Sulfonylureas Sales by Country
- 8.1.1 Europe Second Generation Sulfonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Second Generation Sulfonylureas Sales by Country (2021-2026)
- 8.1.3 Europe Second Generation Sulfonylureas Sales Forecast by Country (2027-2032)
- 8.2 Europe Second Generation Sulfonylureas Market Size by Country
- 8.2.1 Europe Second Generation Sulfonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Second Generation Sulfonylureas Market Size by Country (2021-2026)
- 8.2.3 Europe Second Generation Sulfonylureas Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Second Generation Sulfonylureas Sales by Country
- 9.1.1 Asia-Pacific Second Generation Sulfonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Second Generation Sulfonylureas Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Second Generation Sulfonylureas Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Second Generation Sulfonylureas Market Size by Country
- 9.2.1 Asia-Pacific Second Generation Sulfonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Second Generation Sulfonylureas Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Second Generation Sulfonylureas Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Second Generation Sulfonylureas Sales by Country
- 10.1.1 South America Second Generation Sulfonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Second Generation Sulfonylureas Sales by Country (2021-2026)
- 10.1.3 South America Second Generation Sulfonylureas Sales Forecast by Country (2027-2032)
- 10.2 South America Second Generation Sulfonylureas Market Size by Country
- 10.2.1 South America Second Generation Sulfonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Second Generation Sulfonylureas Market Size by Country (2021-2026)
- 10.2.3 South America Second Generation Sulfonylureas Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Second Generation Sulfonylureas Sales by Country
- 11.1.1 Middle East and Africa Second Generation Sulfonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Second Generation Sulfonylureas Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Second Generation Sulfonylureas Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Second Generation Sulfonylureas Market Size by Country
- 11.2.1 Middle East and Africa Second Generation Sulfonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Second Generation Sulfonylureas Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Second Generation Sulfonylureas Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Second Generation Sulfonylureas Value Chain Analysis
- 12.1.1 Second Generation Sulfonylureas Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Second Generation Sulfonylureas Production Mode & Process
- 12.2 Second Generation Sulfonylureas Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Second Generation Sulfonylureas Distributors
- 12.2.3 Second Generation Sulfonylureas Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst